abiraterone

Generic: abiraterone acetate

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abiraterone
Generic Name abiraterone acetate
Labeler pd-rx pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

abiraterone acetate 250 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 72789-213
Product ID 72789-213_40ac0f51-34ed-e949-e063-6294a90a2366
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208339
Listing Expiration 2026-12-31
Marketing Start 2018-11-23

Pharmacologic Class

Classes
cytochrome p450 17a1 inhibitor [epc] cytochrome p450 17a1 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72789213
Hyphenated Format 72789-213

Supplemental Identifiers

RxCUI
1100075
UPC
0372789213989
UNII
EM5OCB9YJ6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abiraterone (source: ndc)
Generic Name abiraterone acetate (source: ndc)
Application Number ANDA208339 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98)
source: ndc

Packages (1)

Ingredients (1)

abiraterone acetate (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "40ac0f51-34ed-e949-e063-6294a90a2366", "openfda": {"upc": ["0372789213989"], "unii": ["EM5OCB9YJ6"], "rxcui": ["1100075"], "spl_set_id": ["413c645e-074d-4276-b39a-d83521077602"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98)", "package_ndc": "72789-213-98", "marketing_start_date": "20211011"}], "brand_name": "Abiraterone", "product_id": "72789-213_40ac0f51-34ed-e949-e063-6294a90a2366", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "72789-213", "generic_name": "Abiraterone acetate", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208339", "marketing_category": "ANDA", "marketing_start_date": "20181123", "listing_expiration_date": "20261231"}